GeneDx Holdings Corp.’s filing revealed that its Chief Executive Officer Stueland Katherine unloaded Company’s shares for reported $33333.0 on Mar 10. In the deal valued at $0.36 per share,92,644 shares were sold. As a result of this transaction, Stueland Katherine now holds 308,574 shares worth roughly $ 0.11 million.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Then, Saad Kareem sold 35,200 shares, generating $12,665 in total proceeds. Upon selling the shares at $0.36, the Chief Transformation Officer now owns 178,430 shares.
Before that, White Karen Ann sold 32,787 shares. GeneDx Holdings Corp. shares valued at $11,797 were divested by the Chief People Officer at a price of $0.36 per share. As a result of the transaction, White Karen Ann now holds 52,172 shares, worth roughly $18781.92.
Price Performance Review of WGS
On Monday, GeneDx Holdings Corp. [NASDAQ:WGS] saw its stock jump 6.09% to $0.36. On the same session, the stock had its day’s lowest price of $0.272, but rose to a high of $0.38. Over the last five days, the stock has lost -17.29%. GeneDx Holdings Corp. shares have risen nearly 37.98% since the year began. Nevertheless, the stocks have fallen -87.95% over the past one year. While a 52-week high of $3.28 was reached on 02/16/23, a 52-week low of $0.22 was recorded on 01/06/23. SMA at 50 days reached $0.4106, while 200 days put it at $0.9680.
Levels Of Support And Resistance For WGS Stock
The 24-hour chart illustrates a support level at 0.2973, which if violated will result in even more drops to 0.2307. On the upside, there is a resistance level at 0.4053. A further resistance level may holdings at 0.4467. The Relative Strength Index (RSI) on the 14-day chart is 39.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0809, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 64.34%. Stochastics %K at 17.40% indicates the stock is a buying.
How much short interest is there in GeneDx Holdings Corp.?
A steep rise in short interest was recorded in GeneDx Holdings Corp. stocks on Jan 12, 2023, dropping by -0.15 million shares to a total of 6.23 million shares. Yahoo Finance data shows the prior-month short interest on Nov 29, 2022 was 6.38 million shares. There was a decline of -2.41%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 2.42% of the overall stock float, the days-to-cover ratio (short ratio) fell to 2.6.
GeneDx Holdings Corp. [WGS] – Who Are The Largest Shareholders?
In filings from Casdin Capital LLC, it is revealed that the company now owns 102,151,785 shares, or roughly 12.88% of the outstanding WGS shares. In other words, the investor’s shares have risen by 85,714,285 from its previous 13-F filing of 16437500.0. Additionally, Corvex Management LP increased 848.95% of its stake after which the total value it holdings stand at $43,405,758, while Deerfield Management Co. LP added 469.12% of its stake to hold $28.6 million in the firm. Over the last quarter, Goldman Sachs & Co. LLC purchased 12,345,060 shares of GeneDx Holdings Corp., while BlackRock Fund Advisors bought 101,206 shares. At present, The Vanguard Group, Inc. is holding 9,092,286 shares valued at $4.55 million. Marshall Wace LLP owned 6,291,730 shares of the company at the time of its most recent 13F filing, worth $3.15 million.